Caesarstone CSTE 深 沪
已收盘 12-19 16:00:00 美东时间
1.79
+0.070
+4.07%
华盛通- 最 高1.95
- 今 开1.76
- 成交量 8.03万股
- 最 低 0.93
- 昨 收 1.72
- 总市值 6171.20万
- 52周最高 4.67
- 市盈率 静 3.26
- 换手率 0.23%
- 52周最低 0.8581
- 委 比 -98.38%
- 总股本 3447.60万
- 历史最高 70.82
- 量 比 0.39
- 振 幅 59.30%
- 历史最低 0.8581
- 每 手 1
- 风险率 1.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Castle Biosciences granted 66 employees RSUs covering 135,978 shares as inducement for employment, vesting over four years. The company offers innovative diagnostics for skin cancers, Barrett’s esophagus, and uveal melanoma, with R&D programs for other high-need diseases.
06-19 11:00
AgEagle Aerial Systems Secures International Sale of eBee VISION Drones to Paraguayan Government
AgEagle Aerial Systems Inc. has expanded its global UAS presence by selling two eBee VISION drones to the Government of Paraguay. This transaction underscores the company's growing role in international government markets and highlights the reliability and versatility of its advanced drone technology. The eBee VISION's high-resolution imaging and navigation capabilities make it ideal for government operations, further solidifying AgEagle's reputation in the Latin American market.
06-04 12:00
New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes
Castle Biosciences presents study showing DecisionDx-Melanoma reduces mortality risk by 32% in melanoma patients, improving survival through precise risk assessment and personalized treatment.
05-29 20:30
